FDA Committee Members Reviewing Pfizer Vaccine For Children Have Worked For Pfizer, Have Big Pfizer Connections

The FDA’s Vaccines and Related Biological Products Advisory Committee is holding a virtual meeting Tuesday October 26 to discuss authorizing a Pfizer-BioNTech Coronavirus vaccine for children between the ages of 5 to 11 years old.

This committee has a lot of sway with the FDA and their findings will be relevant, considering the Biden administration is getting ready to ship vaccines to elementary schools and California has already mandated the vaccine for schoolchildren pending federal authorization.

But the meeting roster shows that numerous members of the committee and temporary voting members have worked for Pfizer or have major connections to Pfizer.

nationalfile.com/fda-committee-members-reviewing-pfizer-vaccine-for-children-have-worked-for-pfizer-have-big-pfizer-connections/